Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$337K Hold
1,500
0.05% 146
2025
Q4
$361K Hold
1,500
0.05% 141
2025
Q3
$411K Hold
1,500
0.06% 135
2025
Q2
$387K Hold
1,500
0.06% 137
2025
Q1
$336K Hold
1,500
0.06% 143
2024
Q4
$343K Buy
+1,500
New +$361K 0.05% 143

Other funds holding RMD

Harbor Advisors's RMD Position: Q1 2026 in Review

Harbor Advisors held its ResMed (RMD) position steady in Q1 2026 at 1,500 shares worth $337K. The position accounts for 0.05% of the portfolio, ranked #146.

Harbor Advisors first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $411K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Harbor Advisors held 1,500 shares of ResMed worth $337K as of Q1 2026.
  • Harbor Advisors left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.05% of Harbor Advisors's portfolio in Q1 2026, its #146 holding.
  • Harbor Advisors first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • Harbor Advisors's ResMed position peaked at $411K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Harbor Advisors's 13F filing for Q1 2026, filed 7 May 2026.